Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Article
The Intelligence Report
Q2 CASUALTY REPORT 2024
Workers' Comp
Article
Navigating the Complex Landscape of Utilization Review in Workers' Compensation
Utilization Review (UR) plays a crucial role in the workers' compensation system, ensuring that medical treatments provided to injured employees ar
Workers' Comp
News Release
Enlyte’s Q2 Medical Price Index Shows Increases In Comp and Auto Injury Services
New report reveals current trends for P&C industry SAN DIEGO, Calif.—Medical costs nationally have risen 11% in workers
Workers' Comp
Podcast
Return-to-work strategies for LGBTQ+ Injured Employees
Workers' Comp
Article
Looking Beyond the Numbers of Enlyte’s Medical Price Index
Each quarter, Enlyte publishes its medical price index (MPI), which analyzes Enlyte’s medical bill review professional services charge data for tre
Workers' Comp
Article
Enlyte Quarterly Medical Price Index - Q2
As reported by the Bureau of Labor and Statistics (BLS) for April 2024, the